U.S. FDA approves Eli Lilly’s single-injection, once-monthly Omvoh regimen for adults with… EP News Bureau Oct 28, 2025 The approval allows a simplified once-monthly 200 mg maintenance dose of Omvoh (mirikizumab-mrkz) for adults with moderately to…
Biocon starts clinical study to evaluate efficacy of Itolizumab PTI Dec 16, 2022 This is a phase-II randomised, double-blind, parallel-group, placebo and active-controlled (adalimumab), two-treatment period…
Roivant and Pfizer launch unit to develop inflammatory disease drug Reuters Dec 2, 2022 The drug's efficacy as a treatment for ulcerative colitis is currently being assessed in a mid-stage study
Pfizer announces positive results for phase-III trial of Etrasimod in Ulcerative Colitis patients EP News Bureau Mar 24, 2022 Elevate 12 study met primary and key secondary endpoints of improving clinical remission at week 12